However, when primary engrafted human CD45+ cells from +AML patient samples were transplanted into secondary mice, they generated significantly more engraftment than equivalent numbers of human CD45+ cells from the CD34+-alone group. This evidence concerns the gene PTPRC and acute myeloid leukemia.